TLCM
PFE icon

Twin Lakes Capital Management’s Pfizer PFE Stock Holding History

Twin Lakes Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Sell
15,868
-145
-0.9% -$3.79K 0.15% 67
2026
Q1 		$450K Buy
16,013
+95
+0.6% +$2.53K 0.2% 59
2025
Q4 		$396K Buy
15,918
+97
+0.6% +$2.45K 0.18% 66
2025
Q3 		$403K Buy
15,821
+98
+0.6% +$2.42K 0.19% 64
2025
Q2 		$381K Buy
15,723
+97
+0.6% +$2.26K 0.23% 61
2025
Q1 		$396K Sell
15,626
-112
-0.7% -$2.93K 0.27% 59
2024
Q4 		$418K Sell
15,738
-4,360
-22% -$118K 0.27% 56
2024
Q3 		$582K Buy
20,098
+143
+0.7% +$4.17K 0.37% 48
2024
Q2 		$558K Buy
19,955
+146
+0.7% +$4.02K 0.38% 48
2024
Q1 		$550K Buy
19,809
+152
+0.8% +$4.22K 0.37% 50
2023
Q4 		$566K Buy
19,657
+130
+0.7% +$3.93K 0.39% 47
2023
Q3 		$648K Hold
19,527
– – 0.48% 41
2023
Q2 		$716K Buy
19,527
+96
+0.5% +$3.74K 0.51% 41
2023
Q1 		$793K Buy
19,431
+91
+0.5% +$3.93K 0.59% 39
2022
Q4 		$991K Sell
19,340
-11
-0.1% -$527 0.76% 31
2022
Q3 		$847K Buy
19,351
+79
+0.4% +$3.84K 0.68% 33
2022
Q2 		$1.01M Sell
19,272
-93
-0.5% -$4.74K 0.73% 34
2022
Q1 		$1M Buy
19,365
+75
+0.4% +$3.89K 0.57% 44
2021
Q4 		$1.14M Buy
19,290
+78
+0.4% +$3.87K 0.61% 40
2021
Q3 		$826K Buy
19,212
+100
+0.5% +$4.43K 0.48% 43
2021
Q2 		$748K Buy
19,112
+53
+0.3% +$2.06K 0.42% 43
2021
Q1 		$691K Buy
19,059
+735
+4% +$26.1K 0.43% 44
2020
Q4 		$675K Buy
+18,324
New +$672K 0.48% 43

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Twin Lakes Capital Management's PFE Position: Q2 2026 in Review

Twin Lakes Capital Management reduced its Pfizer (PFE) stake by 0.91% in Q2 2026, selling an estimated $3.79K and leaving 15,868 shares worth $382K. The position accounts for 0.15% of the portfolio, ranked #67.

Twin Lakes Capital Management first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.14M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Twin Lakes Capital Management held 15,868 shares of Pfizer worth $382K as of Q2 2026.
  • Twin Lakes Capital Management sold 145 Pfizer shares in Q2 2026, an estimated $3.79K.
  • Pfizer made up 0.15% of Twin Lakes Capital Management's portfolio in Q2 2026, its #67 holding.
  • Twin Lakes Capital Management first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Twin Lakes Capital Management's Pfizer position peaked at $1.14M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Twin Lakes Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.